3 Penny Stocks Set to Pass the $5 Mark Soon

08:13am, Friday, 23'rd Jun 2023
The conventional definition of a penny stock is one that trades below $1. However, it's more common to define a penny stock as any stock that trades for less than $5.
The M&A market is under the weather. Nearly halfway into 2023, global transaction values total $1.1 trillion, $900 billion less than this point last year.
Atossa Therapeutics Inc (NASDAQ:ATOS) announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (No 11,680,036) directed to the company's enterically encapsulated e
SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet
Breast cancer is the leading cause of cancer death in American women, with around 280,000 women diagnosed annually, so anything that can predict the path of the disease and hopefully prevent its occur
Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, revealed that the pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE study, evaluati
Atossa Therapeutics Inc (NASDAQ:ATOS) has found its new chief financial officer in veteran life sciences executive and longtime board member Greg Weaver.  Weaver brings more than 30 years of life sci
Breast cancer drug clinical trial milestones and mergers and acquisitions (M&A) in 2023 should be catalysts for Atossa Therapeutics Inc (NASDAQ:ATOS)' stock, according to analysts at Ascendiant Capita
Atossa Therapeutics Inc (NASDAQ:ATOS) CEO Steven Quay has offered a set of recommendations to the United States Preventive Services Task Force (USPSTF) following the release of a draft report on breas
Atossa Therapeutics, Inc has announced that it will present a Trial in Progress poster for the Phase 2 clinical study of (Z)-endoxifen in premenopausal women with early stage ER+ / HER2- breast cancer
SEATTLE, May 09, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet

3 Best Penny Stocks Under $1 to Buy in April

08:36pm, Tuesday, 11'th Apr 2023
As with all speculative investments, today's list of the best penny stocks under $1 should be approached with caution. Penny stocks are arguably one of the best ways to see outsized returns.
Typically, penny stocks are pure market wages for hardened gamblers. In fact, penny stocks are always risky — especially some of the best biotech stocks under $1 – and should oftentimes be avoided
SEATTLE, March 15, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unme
Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE